Quantbot Technologies’s Royalty Pharma RPRX Stock Holding History

Quantbot Technologies’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Sell	28,687 -75,369	-72%	-$3.3M	0.06%	491
2025 Q4	$4.02M	Buy	104,056 +24,095	+30%	+$919K	0.13%	236
2025 Q3	$2.82M	Buy	+79,961	New	+$2.89M	0.08%	407
2023 Q3	–	Sell	-25,626	Closed	-$788K	–	1900
2023 Q2	$788K	Buy	25,626 +19,651	+329%	+$666K	0.05%	512
2023 Q1	$215K	Buy	5,975 +5,170	+642%	+$192K	0.02%	887
2022 Q4	$31.8K	Sell	805 -184	-19%	-$7.68K	﹤0.01%	1380
2022 Q3	$39K	Buy	+989	New	+$42.2K	﹤0.01%	1286
2022 Q1	–	Sell	-9,601	Closed	-$382K	–	1993
2021 Q4	$382K	Buy	+9,601	New	+$373K	0.03%	598

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Quantbot Technologies's RPRX Position: Q1 2026 in Review

Quantbot Technologies reduced its Royalty Pharma (RPRX) stake by 72% in Q1 2026, selling an estimated $3.3M and leaving 28,687 shares worth $1.38M. The position accounts for 0.06% of the portfolio, ranked #491.

Quantbot Technologies first reported a position in RPRX in Q4 2021 and has held it in 8 quarters since. The position peaked at $4.02M in Q4 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Quantbot Technologies held 28,687 shares of Royalty Pharma worth $1.38M as of Q1 2026.
Quantbot Technologies sold 75,369 Royalty Pharma shares in Q1 2026, an estimated $3.3M.
Royalty Pharma made up 0.06% of Quantbot Technologies's portfolio in Q1 2026, its #491 holding.
Quantbot Technologies first reported a position in Royalty Pharma in Q4 2021 and has held it in 8 quarters since.
Quantbot Technologies's Royalty Pharma position peaked at $4.02M in Q4 2025.
587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.